Crohn's disease
Fosmanogepix is a novel-class i.v. and oral antifungal with activity against yeasts and molds.
AUP-16 multi-targeting therapy for chronic wounds (Diabetic Foot Ulcers...) shows 50% improvement vs placebo in Phase-2 RCT
